How Bristol-Myers Squibb Company (BMY) Delivers Strong Yields Even in Tough Markets

Core Insights - Bristol-Myers Squibb Company (NYSE:BMY) is recognized as one of the 10 Best Recession Proof Dividend Stocks to Buy [1] - The company operates primarily in the branded pharmaceuticals sector, characterized by high entry barriers and strong profitability [2] - Successful drug development can yield billions in revenue, supported by long-lasting patent protection [3] Financial Performance - During the 2007–09 financial crisis, Bristol-Myers Squibb's stock declined only 32%, significantly better than the broader market's drop of over 50% [3] - The company currently pays a quarterly dividend of $0.62 per share, resulting in a dividend yield of 5.62% as of September 26 [4] - Bristol-Myers Squibb has a track record of increasing its dividend payouts for 16 consecutive years [4]